Grounded in research and strong financial and scientific communications expertise, Real Chemistry’s IR practice creates opportunities for public and private companies to differentiate their investment stories, define their value propositions and secure new relationships within the investment community. Our experienced in-house and large IR advisory team has extensive Wall Street and financial communications backgrounds and proven track records of achieving client goals.

From pre-IPO to commercial progress, we offer a full suite of integrated capabilities to advise companies on a broad range of ongoing and “one-time” special situations for their communications and engagement with the investment community. By leveraging a communications platform steeped in analytics and employing traditional communications and digital strategies, we create and execute custom-designed investor relations programs that raise awareness and promote our clients’ value propositions designed to provide shareholder value.

IR Service Offerings:

• IPOs, financings, & roadshows
• Quarterly & annual reporting
• Milestone and medical meeting support
• Financial media
• Corporate presentations
• Investor & analyst targeting/outreach
• IR analytics
• Investor days
• Perception studies
• M&A and transactions
• Activist planning & strategy
• Crisis management
• ESG planning & strategy

Real Chemistry’s mission is to transform what healthcare is to what it should be by leveraging the industry’s most advanced AI-powered insights, diverse expertise and customer-centric ideas. The investor relations practice is an integral component in driving this mission, by utilizing analytics and communications to elevate healthcare and life science companies.